Advanced Search

 

Study ID Status Title Patient Level Data
204682 Completed An Open-label Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Subjects with Type 2 Diabetes Mellitus
204685 Recruiting A 2-part randomized, double-blind (sponsor-unblinded), placebo-controlled, ascending dose and parallel group study of TLR4 agonist (GSK1795091) administered to healthy subjects
204687 Active, Not Recruiting Assessment of safety of GlaxoSmithKline (GSK) Vaccines’ quadrivalent seasonal influenza vaccine, Fluarix Tetra when administered according to the approved Prescribing Information in Korea.
204691 Recruiting A Phase I Open Label Study of GSK3359609 Administered Alone and in Combination with Anticancer Agents in Subjects with Selected Advanced Solid Tumors
204697 Not yet recruiting A phase IB open-label, dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with androgen deprivation therapy and other agents in subjects with castrate-resistant prostate cancer (CRPC)
204699 Completed A randomized double-blind (sponsor unblind) placebo controlled study in healthy subjects to evaluate: safety, tolerability, pharmacokinetics, and pharmacodynamics of the repeat doses of GSK2881078, the Selective Androgen Receptor Modulator with an open label dosing arm to evaluate the effect of CYP3A4 inhibition on pharmacokinetics of GSK2881078
204710 Not yet recruiting A Multinational, Single Arm, Observational Study to Evaluate the Real-world Effectiveness and Pattern of Use of Mepolizumab in Patients with Severe Eosinophilic Asthma (204710)
204715 Not yet recruiting A study of single doses to evaluate the safety, tolerability, pharmacokinetics and target engagement of nebulised GSK3008348 in idiopathic pulmonary fibrosis patients, using positron emission tomography (PET) imaging
204716 Active, not recruiting A 24-week, Phase III, open-label, non-comparative, multi-center study to evaluate efficacy and safety of GSK1278863 in Japanese hemodialysis subjects with anemia associated with chronic kidney disease who are not taking erythropoiesis stimulating agents
204725 Completed An Open Label, Randomized, Single Dose, Crossover study to determine the Pharmacokinetics of Three Tablet Formulations of GSK2798745 in Healthy Subjects
204729 Completed A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Ascending Dose Escalating, 4 Period Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of Single Doses of GSK3179106, a REarranged during Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Normal Healthy Volunteers
204731 Recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of TRIUMEQ administered in Korean subjects for treatment of HIV-1 infection in real life practice
204736 Completed Sun Protection Factor Determination (In vivo determination of the sun protection factor ISO 24444) (61-SPF-iM)
204738 Completed The effects of 2 consecutive days of multiple highintensity exercise bouts on cognitive function, mood and fatigue state in well-trained intermittent sports players.
204739 Completed Study to investigate the initial stages of enamel erosion in vivo
204740 Recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of VOLIBRIS in Korean subjects in usual practice
204745 Recruiting An open-label, single arm study to investigate the safety, pharmacokinetics and pharmacodynamics of repeat doses of inhaled GSK2269557 in patients with APDS/PASLI
204746 Recruiting A microdose Study to Evaluate the Biodistribution of [11C]-GSK2256098 in the Lungs and Heart of Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients using Positron Emission Tomography (PET)
204749 Completed Heat, eat, compete: Investigating the application of localised heating on muscle glycogen
204752 Not yet recruiting Clinical, Single-blind and Controlled Study of the Potential of Cutaneous Photosensitization and Phototoxicity of a cosmetic product SM
204753 Not yet recruiting Clinical, Single-blind and Controlled Study of the Potential of Cutaneous Photosensitization and Phototoxicity of a cosmetic product SM
204754 Not yet recruiting Clinical, Single-blind and Controlled Study of the Potential of Cutaneous Photosensitization and Phototoxicity of a cosmetic product SM - 204754
204755 Not yet recruiting Clinical, Single-blind and Controlled Study of the Potential of Irritability and Cutaneous Sensitization (RIPT) of a Cosmetic product SM.
204756 Not yet recruiting Clinical, Single-blind and Controlled Study of the Potential of Irritability and Cutaneous Sensitization (RIPT) of a Cosmetic product SM.
204757 Not yet recruiting Clinical, Single-blind and Controlled Study of the Potential of Irritability and Cutaneous Sensitization (RIPT) of a Cosmetic product SM

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.